Free Trial

Quantum Biopharma (QNTM) Competitors

Quantum Biopharma logo
$13.90 -0.54 (-3.74%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$14.12 +0.23 (+1.62%)
As of 10/24/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QNTM vs. ZURA, MDWD, PYXS, TARA, GNFT, RANI, EPRX, CHRS, SAVA, and ELDN

Should you be buying Quantum Biopharma stock or one of its competitors? The main competitors of Quantum Biopharma include Zura Bio (ZURA), MediWound (MDWD), Pyxis Oncology (PYXS), Protara Therapeutics (TARA), GENFIT (GNFT), Rani Therapeutics (RANI), Eupraxia Pharmaceuticals (EPRX), Coherus Oncology (CHRS), Cassava Sciences (SAVA), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "pharmaceutical products" industry.

Quantum Biopharma vs. Its Competitors

Zura Bio (NASDAQ:ZURA) and Quantum Biopharma (NASDAQ:QNTM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Quantum Biopharma had 2 more articles in the media than Zura Bio. MarketBeat recorded 4 mentions for Quantum Biopharma and 2 mentions for Zura Bio. Zura Bio's average media sentiment score of 1.36 beat Quantum Biopharma's score of 0.50 indicating that Zura Bio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zura Bio
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quantum Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Zura Bio is trading at a lower price-to-earnings ratio than Quantum Biopharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zura BioN/AN/A-$45.39M-$0.70-5.27
Quantum BiopharmaN/AN/A-$14.20M-$14.02-0.99

Zura Bio's return on equity of -49.11% beat Quantum Biopharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Zura BioN/A -49.11% -40.06%
Quantum Biopharma N/A -270.22%-131.87%

Zura Bio has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Quantum Biopharma has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

Zura Bio currently has a consensus target price of $11.60, indicating a potential upside of 214.36%. Given Zura Bio's stronger consensus rating and higher possible upside, equities analysts clearly believe Zura Bio is more favorable than Quantum Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zura Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
Quantum Biopharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

61.1% of Zura Bio shares are held by institutional investors. Comparatively, 1.2% of Quantum Biopharma shares are held by institutional investors. 14.2% of Zura Bio shares are held by insiders. Comparatively, 8.5% of Quantum Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Zura Bio beats Quantum Biopharma on 10 of the 14 factors compared between the two stocks.

Get Quantum Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QNTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QNTM vs. The Competition

MetricQuantum BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$53.04M$3.46B$6.21B$10.81B
Dividend YieldN/A2.28%5.72%4.80%
P/E Ratio-0.9928.5131.6030.98
Price / SalesN/A497.40595.06133.64
Price / CashN/A46.9537.2561.86
Price / Book3.0610.4012.056.61
Net Income-$14.20M-$52.83M$3.34B$277.10M
7 Day Performance-1.84%2.10%1.94%2.57%
1 Month Performance-14.83%10.17%6.88%3.20%
1 Year Performance145.41%16.57%56.06%33.22%

Quantum Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QNTM
Quantum Biopharma
0.4823 of 5 stars
$13.90
-3.7%
N/A+145.6%$53.04MN/A-0.99N/AAnalyst Forecast
Gap Up
ZURA
Zura Bio
3.0024 of 5 stars
$3.36
-0.4%
$11.60
+245.8%
-22.2%$218.14MN/A-4.793
MDWD
MediWound
1.9916 of 5 stars
$19.50
-1.0%
$32.25
+65.4%
+5.5%$216.14M$19.86M-7.3880Analyst Forecast
PYXS
Pyxis Oncology
2.8855 of 5 stars
$3.48
-2.8%
$7.75
+122.7%
-5.5%$215.82M$2.82M-2.1760Analyst Forecast
TARA
Protara Therapeutics
1.8472 of 5 stars
$5.48
-1.4%
$19.60
+257.7%
+125.7%$211.42MN/A-3.3830News Coverage
Analyst Forecast
GNFT
GENFIT
2.1393 of 5 stars
$4.16
+1.8%
$7.00
+68.5%
-22.1%$207.75M$76.77M0.00120
RANI
Rani Therapeutics
3.2381 of 5 stars
$2.88
+28.0%
$8.50
+195.0%
-22.2%$206.98M$1.20M-3.16110News Coverage
Analyst Forecast
Insider Trade
Analyst Revision
High Trading Volume
EPRX
Eupraxia Pharmaceuticals
2.995 of 5 stars
$5.70
-3.1%
$11.00
+93.0%
+112.0%$204.97MN/A-6.7129Analyst Forecast
Short Interest ↑
CHRS
Coherus Oncology
4.1885 of 5 stars
$1.75
-2.5%
$4.51
+158.6%
+110.5%$202.82M$272.21M1.13330News Coverage
Analyst Forecast
SAVA
Cassava Sciences
2.4 of 5 stars
$4.09
-7.4%
$2.00
-51.0%
-85.8%$198.31MN/A-1.6130Options Volume
ELDN
Eledon Pharmaceuticals
2.1979 of 5 stars
$3.31
-5.4%
$10.00
+202.0%
+2.7%$198.26MN/A-2.8310Analyst Forecast

Related Companies and Tools


This page (NASDAQ:QNTM) was last updated on 10/26/2025 by MarketBeat.com Staff
From Our Partners